The tacky and deformable properties of a wax-like drug-fatty acid salt, pro
pranolol oleate (POA), make particle size reduction and separation challeng
ing. The aim of this study was to investigate the use of POA as binder in a
melt granulation procedure to improve processing properties. POA is a suit
able candidate for binder phase in melt granulation with a melting temperat
ure of 50 56 degreesC. Small batches (ca 30 g) were manufactured using a hi
gh shear mixer with lactose monohydrate as the substrate phase. Optimum uni
formity of drug content and minimum friability were found at 10% w/w POA bi
nder concentration. POA melt granules exhibited a > 10-fold increase in the
rate of in vitro dissolution at pH 7.4 with 0.2% w/v sodium lauryl sulphat
e compared with raw POA. The increased drug surface area in granular form w
as thought to be responsible for the change in dissolution behaviour. This
study has demonstrated that melt granulation using POA as binder is a viabl
e process which leads to beneficial changes in dissolution behaviour for th
e lipophilic drug-fatty acid salt. (C) 2000 Elsevier Science B.V. All right
s reserved.